Arimoclomol: Difference between revisions
CSV import |
CSV import |
||
| Line 38: | Line 38: | ||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
[[Category:Neurodegenerative disorders]] | [[Category:Neurodegenerative disorders]] | ||
<gallery caption="Arimoclomol"> | |||
File:Arimoclomol.svg|Arimoclomol | |||
</gallery> | |||
Revision as of 00:44, 20 February 2025
An investigational drug for neurodegenerative diseases
| Arimoclomol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Arimoclomol is a pharmacological agent that has been investigated for its potential therapeutic effects in various neurodegenerative diseases. It is known for its ability to modulate the heat shock response, a cellular defense mechanism against stress.
Mechanism of Action
Arimoclomol functions by amplifying the production of heat shock proteins (HSPs), which are crucial in maintaining cellular protein homeostasis. These proteins assist in the proper folding of nascent proteins and the refolding or degradation of misfolded proteins, thus protecting cells from stress-induced damage. By enhancing the heat shock response, arimoclomol aims to mitigate the pathological processes associated with neurodegenerative conditions.
Therapeutic Applications
Arimoclomol has been studied in the context of several neurodegenerative disorders, including:
In these conditions, the accumulation of misfolded proteins and cellular stress are key pathological features. Arimoclomol's ability to boost the heat shock response offers a potential therapeutic strategy to alleviate these issues.
Clinical Trials
Clinical trials have been conducted to evaluate the efficacy and safety of arimoclomol in patients with neurodegenerative diseases. These trials aim to determine the drug's impact on disease progression, symptom management, and overall quality of life for patients.
Safety and Side Effects
The safety profile of arimoclomol has been assessed in various clinical studies. Common side effects reported include mild gastrointestinal disturbances and headache. The drug is generally well-tolerated, but ongoing studies continue to monitor its long-term safety.
Future Directions
Research into arimoclomol is ongoing, with scientists exploring its potential applications in other diseases characterized by protein misfolding and cellular stress. The drug's ability to modulate the heat shock response makes it a promising candidate for further investigation in the field of neurodegeneration.
Related Pages
- Arimoclomol
-
Arimoclomol
